Seongmin Choi

Mr. Seongmin Choi

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 July 2025 in Nature
Verified
Journal Article
Open access
PDF file
AMAndrew William McPherson
Andrew William McPherson
IVIgnacio Vázquez-García
Ignacio Vázquez-García
MMMatthew A. Myers
Matthew A. Myers
DADuaa H. Al-Rawi
Duaa H. Al-Rawi
MZMatthew Zatzman
Matthew Zatzman
SSSohrab P. Shah
Sohrab P. Shah
Whole-genome doubling (WGD) is a common feature of human cancers and is linked to tumour progression, drug resistance, and metastasis1,2,3,4,5,6. Here we examine the impact of WGD on somatic evolution and immune evasion at single-cell resolution in patient tumours. Using single-cell whole-genome sequencing, we analysed 70 high-grade serous ovarian cancer samples from 41 patients (30,260 tumour genomes) and observed near-ubiquitous evidence that WGD is an ongoing mutational process. WGD was associated with increased cell–cell diversity and higher rates of chromosomal missegregation and consequent micronucleation. We developed a mutation-based WGD timing method called doubleTime to delineate specific modes by which WGD can drive tumour evolution, including early fixation followed by considerable diversification, multiple parallel WGD events on a pre-existing background of copy-number diversity, and evolutionarily late WGD in small clones and individual cells. Furthermore, using matched single-cell RNA sequencing and high-resolution immunofluorescence microscopy, we found that inflammatory signalling and cGAS-STING pathway activation result from ongoing chromosomal instability, but this is restricted to predominantly diploid tumours (WGD-low). By contrast, predominantly WGD tumours (WGD-high), despite increased missegregation, exhibited cell-cycle dysregulation, STING1 repression, and immunosuppressive phenotypic states. Together, these findings establish WGD as an ongoing mutational process that promotes evolvability and dysregulated immunity in high-grade serous ovarian cancer.

27 July 2020 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AMAhrum Min
Ahrum Min
KWANGSOO KIMKWANGSOO KIM
KWANGSOO KIM
KJKyeonghun Jeong
Kyeonghun Jeong
SCSeongmin Choi
Seongmin Choi
SKSeongyeong Kim
Seongyeong Kim
SISeock-Ah Im
Seock-Ah Im
Breast cancer (BC) in patients with germline mutations ofBRCA1/BRCA2are associated with benefit from drugs targeting DNA damage response (DDR), but they account for only 5–7% of overall breast cancer. To define the characteristics of these tumors and also to identify tumors without BRCA mutation but with homologous recombination deficiency (HRD) is clinically relevant. To define characteristic features of HRD tumors and analyze the correlations betweenBRCA1/BRCA2and BC subtypes, we analyzed 981 breast tumors from the TCGA database using the signature analyzer. The BRCA signature was strongly associated with the HRD score top 10% (score ≥ 57) population. This population showed a high level of mutations in DDR genes, includingBRCA1/BRCA2. HRD tumors were associated with high expression levels ofBARD1andBRIP1. Besides,BRCA1/2 mutations were dominantly observed in basal and luminal subtypes, respectively. A comparison of HRD features in BC revealed thatBRCA1exerts a stronger influence inducing HRD features thanBRCA2does. It reveals genetic differences betweenBRCA1andBRCA2and provides a basis for the identification of HRD and other BRCA-associated tumors.

Verified
Journal Article
Open access
PDF file
YCYoung Jun Chai
Young Jun Chai
HCHeejoon Chae
Heejoon Chae
KWANGSOO KIMKWANGSOO KIM
KWANGSOO KIM
HLHeonyi Lee
Heonyi Lee
SCSeongmin Choi
Seongmin Choi
SKSang Wan Kim
Sang Wan Kim
Parathyroid adenoma is the main cause of primary hyperparathyroidism, which is characterized by enlarged parathyroid glands and excessive parathyroid hormone secretion. Here, we performed transcriptome analysis, comparing parathyroid adenomas with normal parathyroid gland tissue. RNA extracted from ten parathyroid adenoma and five normal parathyroid samples was sequenced, and differentially expressed genes (DEGs) were identified using strict cut-off criteria. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed using DEGs as the input, and protein-protein interaction (PPI) networks were constructed using Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) and visualized in Cytoscape. Among DEGs identified in parathyroid adenomas (n = 247; 45 up-regulated, 202 down-regulated), the top five GO terms for up-regulated genes were nucleoplasm, nucleus, transcription DNA-template, regulation of mRNA processing, and nucleic acid binding, while those for down-regulated genes were extracellular exosome, membrane endoplasmic reticulum (ER), membrane, ER, and melanosome. KEGG enrichment analysis revealed significant enrichment of five pathways: protein processing in ER, protein export, RNA transport, glycosylphosphatidylinositol-anchor biosynthesis, and pyrimidine metabolism. Further, PPI network analysis identified a densely connected sub-module, comprising eight hub molecules: SPCS2, RPL23, RPL26, RPN1, SEC11C, SEC11A, RPS25, and SEC61G. These findings may be helpful in further analysis of the mechanisms underlying parathyroid adenoma development.

1 January 2020 in Investigative and Clinical Urology
Verified
Journal Article
Open access
PDF file
JSJungyo Suh
Jungyo Suh
CJChang Wook Jeong
Chang Wook Jeong
SCSeongmin Choi
Seongmin Choi
JKJa Hyun Ku
Ja Hyun Ku
HKHyeon-Hoe Kim
Hyeon-Hoe Kim
CKCheol Kwak
Cheol Kwak
Suh J, et al. Investig Clin Urol. 2020 Mar;61(2):127-135. https://doi.org/10.4111/icu.2020.61.2.127

5 August 2026 in Nature
Verified
Journal Article
Open access
PDF file
DEDina ElHarouni
Dina ElHarouni
MAMushriq Al-Jazrawe
Mushriq Al-Jazrawe
SCSeongmin Choi
Seongmin Choi
MDMerve Dede
Merve Dede
THToshinori Hinoue
Toshinori Hinoue
JBJesse S. Boehm
Jesse S. Boehm
The development of new therapeutics and the validation of pathogenetic cancer mechanisms require representative laboratory models 1,2 . However, existing collections represent only a fraction of the diversity observed in human cancer 2–4 . Recent technologies have enabled efficient in vitro model derivation (for example, tumour organoids) 5 . However, whether these maintain essential properties of patient tumours during long-term expansion has not been systematically investigated. Here we present results of a large-scale international programme—the Human Cancer Models Initiative—which involved the generation of a resource of 665 next-generation models from 2,780 donors with 25 cancer types and integrated tumour–model whole genome, exome, methylome and transcriptome analyses. The resource provides 522 models with comprehensive clinical data, 153 models of rare cancers and 71 models from participants with non-European ancestry. Analyses of 421 matched tumour–model pairs reveal high genetic (97.8%) and epigenetic (95%) concordance and define correlates of model discordance. Single-nucleus RNA sequencing of tumour–model pairs reveals subsets of models in which culture conditions significantly influence cell states. Finally, we characterize model preservation of extrachromosomal DNA and post-treatment mutational signatures to provide opportunities to study therapeutic resistance. This model repository is being made available to the community—including multimodal molecular profiling, clinical information and integrative software tools—thus providing a valuable resource for preclinical investigation of cancer pathogenesis and treatment response.

23 June 2020 in Cancers
Verified
Journal Article
Open access
PDF file
JKJiwon Koh
Jiwon Koh
IJInsoon Jang
Insoon Jang
SCSeongmin Choi
Seongmin Choi
SKSehui Kim
Sehui Kim
IJIngeon Jang
Ingeon Jang
YJYOON KYUNG JEON
YOON KYUNG JEON
Nodal marginal zone lymphoma (NMZL) is a rare B-cell neoplasm, the genetic and transcriptomic landscape of which are unclear. Using high-throughput sequencing for whole-exome and transcriptome, we investigated the genetic characteristics of NMZL in a discovery cohort (n = 8) and validated their features in an extended cohort (n = 30). Novel mutations in NFKBIE and ITPR2 were found in 7.9% (3/38) and 13.9% (5/36), respectively, suggesting roles for the NF-κB pathway and B-cell-receptor-mediated calcium signaling pathway in the pathogenesis of NMZL. RNA-seq showed that NMZLs were characterized by an aberrant marginal zone differentiation, associated with an altered IRF4-NOTCH2 axis and the enrichment of various oncogenic pathways. Based on gene expression profile, two subgroups were identified. Compared with subgroup 1, subgroup 2 showed the following: the significant enrichment of cell cycle-associated and MYC-signaling pathways, a more diverse repertoire of upstream regulators, and higher Ki-67 proliferation indices. We designated two subgroups according to Ki-67 labeling, and subgroup 2 was significantly associated with a shorter progression-free survival (p = 0.014), a greater proportion of large cells (p = 0.009), and higher MYC expression (p = 0.026). We suggest that NMZL has unique features and, in this study, we provide information as to the heterogeneity of this enigmatic entity.